MAPK1 and gastric cancer: As mentioned above, GATA3 is a substrate of USP21 involved in immune tolerance, and this interaction was also found in gastric cancer, which further facilitated the malignant progression of gastric cancer by promoting MAPK1 (also known as ERK2) expression (Guo Q. et al., 2021).